BioCentury | May 15, 2006
Company News

Chelsea, Synergia deal

...CHTP signed a letter of intent to acquire Synergia's IP covering a controlled-release formulation of droxidopa...
...a synthetic amino acid, is marketed in Japan. Chelsea Therapeutics International Ltd. (CHTP), Charlotte, N.C. Synergia Pharma Inc....
BioCentury | May 2, 2005
Finance

MPM's portfolio

...B 8/19/03 $40.0 Dennis Henner Sention Neurology U.S. ND 2/12/02 $13.0 Nicholas Galakatos, Steven Bergman Synergia...
BioCentury | Feb 17, 2003
Company News

Synergia board of directors update

Synergia Pharma Inc. , South San Francisco, Calif. Business: Neurological Appointed: Dennis Henner, general partner of MPM Capital; and William Greene, principal of MPM Capital WIR Staff Neurology...
Items per page:
1 - 3 of 3
BioCentury | May 15, 2006
Company News

Chelsea, Synergia deal

...CHTP signed a letter of intent to acquire Synergia's IP covering a controlled-release formulation of droxidopa...
...a synthetic amino acid, is marketed in Japan. Chelsea Therapeutics International Ltd. (CHTP), Charlotte, N.C. Synergia Pharma Inc....
BioCentury | May 2, 2005
Finance

MPM's portfolio

...B 8/19/03 $40.0 Dennis Henner Sention Neurology U.S. ND 2/12/02 $13.0 Nicholas Galakatos, Steven Bergman Synergia...
BioCentury | Feb 17, 2003
Company News

Synergia board of directors update

Synergia Pharma Inc. , South San Francisco, Calif. Business: Neurological Appointed: Dennis Henner, general partner of MPM Capital; and William Greene, principal of MPM Capital WIR Staff Neurology...
Items per page:
1 - 3 of 3